HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hua Naranmandura Selected Research

monomethylmonothioarsonic acid

9/2011Comparative toxicity of arsenic metabolites in human bladder cancer EJ-1 cells.
9/2010Distribution and speciation of arsenic after intravenous administration of monomethylmonothioarsonic acid in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hua Naranmandura Research Topics

Disease

21Neoplasms (Cancer)
04/2022 - 03/2008
20Acute Promyelocytic Leukemia
08/2021 - 07/2012
7Leukemia
01/2020 - 08/2014
5Body Weight (Weight, Body)
11/2016 - 08/2006
5Urinary Bladder Neoplasms (Bladder Cancer)
09/2011 - 08/2007
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 01/2018
2Carcinogenesis
01/2018 - 09/2011
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022
1Hyperthermia
07/2021
1Anaplastic Thyroid Carcinoma
02/2021
1Thyroid Neoplasms (Thyroid Cancer)
02/2021
1Genomic Instability
01/2021
1Colorectal Neoplasms (Colorectal Cancer)
05/2019
1Hepatocellular Carcinoma (Hepatoma)
12/2017
1Macular Degeneration (Age-Related Maculopathy)
01/2015
1Breast Neoplasms (Breast Cancer)
01/2015
1B-Cell Lymphoma (Lymphoma, B Cell)
02/2014
1Lymphoma (Lymphomas)
02/2014
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2014
1Hematologic Neoplasms (Hematological Malignancy)
12/2013
1Multiple Myeloma
06/2013
1Rheumatoid Arthritis
11/2012
1Type 2 Diabetes Mellitus (MODY)
11/2012
1Necrosis
04/2010
1Hyperplasia
04/2010
1Myoclonus (Nocturnal Myoclonus)
06/2009
1Dyskinesias (Dyskinesia)
06/2009
1Articulation Disorders (Speech Articulation Disorder)
06/2009
1Sleep Wake Disorders
06/2009
1Tremor (Tremors)
06/2009
1Cerebellar Ataxia (Dysmetria)
06/2009
1Cardiovascular Diseases (Cardiovascular Disease)
03/2008
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2007

Drug/Important Bio-Agent (IBA)

19ArsenicIBA
07/2021 - 08/2006
15Arsenic Trioxide (Trisenox)FDA Link
08/2021 - 06/2013
10Proteins (Proteins, Gene)FDA Link
04/2022 - 01/2018
7Pharmaceutical PreparationsIBA
12/2021 - 12/2017
6arseniteIBA
10/2011 - 08/2006
4Arsenicals (Arsenic Compounds)IBA
12/2017 - 08/2007
4dimethylarsinous acidIBA
09/2011 - 04/2007
3Nucleotide AptamersIBA
12/2021 - 02/2019
3RNA (Ribonucleic Acid)IBA
12/2021 - 02/2019
3Single-Stranded DNA (DNA, Single Stranded)IBA
12/2021 - 02/2019
3AntibodiesIBA
02/2021 - 02/2014
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2015 - 08/2007
3monomethylarsonous acidIBA
08/2014 - 04/2007
3arsenic acid (arsenate)IBA
02/2013 - 08/2007
3Cacodylic Acid (Cacodylate)IBA
09/2011 - 08/2007
2venetoclaxIBA
01/2022 - 01/2020
2Oncogene Proteins (Oncogene Protein)IBA
07/2021 - 12/2019
2Doxorubicin (Adriamycin)FDA LinkGeneric
02/2021 - 02/2019
2AntigensIBA
02/2021 - 02/2014
2oxophenylarsine (phenylarsine oxide)IBA
01/2019 - 12/2017
2cryptotanshinoneIBA
01/2015 - 06/2013
2monomethyl auristatin EIBA
02/2014 - 09/2013
2CarcinogensIBA
08/2012 - 07/2012
2dimethylmonothioarsinic acidIBA
09/2011 - 08/2007
2monomethylmonothioarsonic acidIBA
09/2011 - 09/2010
2Drinking WaterIBA
04/2010 - 08/2007
1ponatinibIBA
01/2022
1Co-Repressor ProteinsIBA
07/2021
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
07/2021
1UbiquitinIBA
07/2021
1IodineIBA
02/2021
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
02/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1leptomycin BIBA
12/2019
1Sialic Acid Binding Ig-like Lectin 3IBA
02/2019
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
01/2019
1Staphylococcal Protein A (Protein A)IBA
01/2018
1Therapeutic UsesIBA
01/2015
1Retinaldehyde (Retinal)IBA
01/2015
1Valine (L-Valine)FDA Link
02/2014
1CitrullineIBA
02/2014
1Cathepsin BIBA
02/2014
1DipeptidesIBA
02/2014
1ofatumumabFDA Link
02/2014
1auristatinIBA
02/2014
1Cytotoxins (Cytolysins)IBA
02/2014
1Antineoplastic Agents (Antineoplastics)IBA
12/2013
1TNF-Related Apoptosis-Inducing LigandIBA
09/2013
1CathepsinsIBA
09/2013
1Antimitotic AgentsIBA
09/2013
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
06/2013
1Aligeron (AS 2)IBA
06/2013
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
11/2012
1Multidrug Resistance-Associated Protein 2IBA
10/2011
1dimethyldithioarsinic acidIBA
09/2011
1monomethylarsonic acid (MSMA)IBA
09/2011
1SulfurIBA
09/2011
1sodium arsenite (sodium metaarsenite)IBA
04/2010
1Chemical Warfare AgentsIBA
06/2009
1ChloridesIBA
06/2009
1Environmental Pollutants (Pollutants, Environmental)IBA
06/2009
1Cyanides (Isocyanides)IBA
06/2009
1diphenylarsinic acidIBA
06/2009
1AcidsIBA
03/2008

Therapy/Procedure

10Therapeutics
12/2021 - 02/2014
2Drug Therapy (Chemotherapy)
04/2022 - 12/2021
1Intravenous Injections
08/2006